Stefan Nilsson's most recent trade in Envista Holdings Corp was a trade of 804 Common Stock done at an average price of $21.1 . Disclosure was reported to the exchange on Aug. 25, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Envista Holdings Corp | Stefan Nilsson | President, Nobel Biocare | Payment of exercise price or tax liability using portion of securities received from the company at price $ 21.12 per share. | 25 Aug 2025 | 804 | 54,941 (0%) | 0% | 21.1 | 16,980 | Common Stock |
| Envista Holdings Corp | Stefan Nilsson | President, Nobel Biocare | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Feb 2025 | 24,010 | 24,010 | - | - | Employee Stock Option (Right to Buy) | |
| Envista Holdings Corp | Stefan Nilsson | President, Nobel Biocare | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Feb 2025 | 18,960 | 18,960 | - | - | Performance Share Unit | |
| Envista Holdings Corp | Stefan Nilsson | President, Nobel Biocare | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Feb 2025 | 10,290 | 55,745 (0%) | 0% | 0 | Common Stock |